NeoBioSys is pleased to announce the start of a new project in September!
We are partners in a European project together with three universities and one SME to study the link between live therapeutics and chronic kidney disease.
We are very excited to be starting this new project, and details will be shared in the coming weeks.
NeoBioSys® was born from the resolve of its two co-founders Nicolas Bourgne and Grégory Chambon to answer the issues of valorization and industrialization of production processes by biotechnology.
Contact us
Navigation
All rights reserved – Neobiosys 2022 – Legal Notice – Created by Coqpit, Digital Agency.
